 |
|
|
 |
|
Rationale:
- Current CDC treatment guidelines recommend hepatitis B vaccination only (without hepatitis B immune globulin) at the time
of exam followed by two more vaccines at 1 to 2 months and 4 to 6 months.
- Vaccinated patients with a history of positive hepatitis B surface antibody do not need testing or treatment.
- If the cost of HBIg and hepatitis B vaccination is prohibitive, delayed administration by 72 hours retains efficacy; therefore,
practitioners must make a timely referral for these services if indicated.
|
|
Evidence:
- The CDC's Sexually Transmitted Diseases Treatment Guidelines, 2006 recommend that the hepatitis B vaccine be administered to sexual assault patients at the time of the initial examination
if they have not been previously vaccinated. Follow-up doses of vaccine should be administered 1 to 2 and 4 to 6 months after
the first dose (77).
|
|
Comments:
|
| FAQs |
|
|
|
Carolyn J. Sachs, MD, MPH has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
|
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2008 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|
Sexual Assault
> Drug Therapy
